44 related articles for article (PubMed ID: 27202665)
1. Quality Control of the Hungarian Nationwide Mammography Screening Programme.
Boncz I; Endrei D; Ágoston I; Vajda R; Csákvári T; Kovács G; Sebestyén A
Value Health; 2014 Nov; 17(7):A740. PubMed ID: 27202665
[No Abstract] [Full Text] [Related]
2. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities.
Boncz I; Sebestyén A; Pintér I; Battyány I; Ember I
J Med Screen; 2008; 15(1):14-7. PubMed ID: 18416949
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options.
Becker N; Hakama M; Nyström L
Eur J Cancer Prev; 2007 Jun; 16(3):225-31. PubMed ID: 17415093
[TBL] [Abstract][Full Text] [Related]
4. Method for determination of the mean fraction of glandular tissue in individual female breasts using mammography.
Jansen JT; Veldkamp WJ; Thijssen MA; van Woudenberg S; Zoetelief J
Phys Med Biol; 2005 Dec; 50(24):5953-67. PubMed ID: 16333166
[TBL] [Abstract][Full Text] [Related]
5. Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey.
Duport N; Ancelle-Park R
Eur J Cancer Prev; 2006 Jun; 15(3):219-24. PubMed ID: 16679864
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
7. [Implementation of performance indicators in the Czech Breast Cancer Screening Programme - results of the regular monitoring].
Májek O; Bartoňková H; Daneš J; Skovajsová M; Dušek L
Klin Onkol; 2014; 27 Suppl 2():113-23. PubMed ID: 25494896
[TBL] [Abstract][Full Text] [Related]
8. Implementation of the European protocol for quality control of the technical aspects of mammography screening in Bulgaria.
Vassileva J; Avramova-Cholakova S; Dimov A; Lichev A
Radiat Prot Dosimetry; 2005; 114(1-3):403-5. PubMed ID: 15933146
[TBL] [Abstract][Full Text] [Related]
9. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
10. Does a national screening programme reduce socioeconomic inequalities in mammography use?
Puddu M; Demarest S; Tafforeau J
Int J Public Health; 2009; 54(2):61-8. PubMed ID: 19247577
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life, anxiety and depression related to mammography screening in Norway.
Hafslund B; Espehaug B; Nortvedt MW
J Clin Nurs; 2012 Nov; 21(21-22):3223-34. PubMed ID: 22937996
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
Olsen AH; Njor SH; Vejborg I; Schwartz W; Dalgaard P; Jensen MB; Tange UB; Blichert-Toft M; Rank F; Mouridsen H; Lynge E
BMJ; 2005 Jan; 330(7485):220. PubMed ID: 15649904
[TBL] [Abstract][Full Text] [Related]
13. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
14. A phantom for the measurement of contrast detail performance in film-screen mammography.
Thompson SR; Faulkner K
Br J Radiol; 1991 Nov; 64(767):1049-55. PubMed ID: 1742587
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer screening in women aged 50-74 years: is there room for improvement?
Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
[TBL] [Abstract][Full Text] [Related]
16. Review of the first 50 cases completed by the RACR mammography QA programme: phantom image quality, processor control and dose considerations.
McLean D; Eckert M; Heard R; Chan W
Australas Radiol; 1997 Nov; 41(4):387-91. PubMed ID: 9409037
[TBL] [Abstract][Full Text] [Related]
17. Experience with the European quality assurance guidelines for digital mammography systems in a national screening programme.
McCullagh J; Keavey E; Egan G; Phelan N
Radiat Prot Dosimetry; 2013 Feb; 153(2):223-6. PubMed ID: 23173219
[TBL] [Abstract][Full Text] [Related]
18. Mammography screening in Denmark.
Vejborg I; Mikkelsen E; Garne JP; Bak M; Lernevall A; Mogensen NB; Schwartz W; Lynge E
Dan Med Bull; 2011 Jun; 58(6):C4287. PubMed ID: 21651881
[TBL] [Abstract][Full Text] [Related]
19. Mammography screening and trust: the case of interval breast cancer.
Solbjør M; Skolbekken JA; Sætnan AR; Hagen AI; Forsmo S
Soc Sci Med; 2012 Nov; 75(10):1746-52. PubMed ID: 22906524
[TBL] [Abstract][Full Text] [Related]
20. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
